Literature DB >> 31526432

Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.

Hanna Allerkamp1, Stefanie Lehner2, Mahnaz Ekhlasi-Hundrieser2, Carsten Detering2, Christiane Pfarrer3, Mario von Depka Prondzinski2.   

Abstract

Von Willebrand disease (VWD), a blood coagulation disorder, is also known to cause angiodysplasia. Hitherto, no animal model has been found with angiodysplasia that can be studied in vivo. In addition, VWD patients tend to have a higher incidence of miscarriages for reasons unknown. Thus, we aimed to examine the influence of von Willebrand factor (VWF) on the female reproductive tract histology and the expression and distribution of angiogenic factors in a porcine model for VWD types 1 and 3. The disease-causing tandem duplication within the VWF gene occurred naturally in these pigs, making them a rare and valuable model. Reproductive organs of 6 animals (2 of each mutant genotype and 2 wildtype (WT) animals) were harvested. Genotype plus phenotype were confirmed. Several angiogenic factors were chosen for possible connections to VWF and analyzed alongside VWF by immunohistochemistry and quantitative gene expression studies. VWD type 3 animals showed angiodysplasia in the uterus and shifting of integrin αVβ₃ from the apical membrane of uterine epithelium to the cytoplasm accompanied by increased vascular endothelial growth factor (VEGF) expression. Varying staining patterns for angiopoietin (Ang)-2 were observed among the genotypes. As compared with WT, the ovaries of the VWD type 3 animals showed decreased gene expression of ANG2 and increased gene expression of TIE (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains) 2, with some differences in the ANG/TIE-system among the mutant genotypes. In conclusion, severely reduced VWF seems to evoke angiodysplasia in the porcine uterus. Varying distribution and expression of angiogenic factors suggest that this large animal model is promising for investigation of influence of VWF on angiogenesis in larger groups.

Entities:  

Year:  2019        PMID: 31526432      PMCID: PMC6807720          DOI: 10.30802/AALAS-CM-19-000003

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  39 in total

1.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

Review 2.  Paracrine signaling in the endometrium: integrins and the establishment of uterine receptivity.

Authors:  B A Lessey; J T Arnold
Journal:  J Reprod Immunol       Date:  1998-08       Impact factor: 4.054

Review 3.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

Review 4.  Telangiectasia: its relationship to the Minot-von Willebrand syndrome.

Authors:  A J Quick
Journal:  Am J Med Sci       Date:  1967-11       Impact factor: 2.378

5.  Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

Authors:  Louise E Reynolds; Lorenza Wyder; Julie C Lively; Daniela Taverna; Stephen D Robinson; Xiaozhu Huang; Dean Sheppard; Richard O Hynes; Kairbaan M Hodivala-Dilke
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 6.  Von Willebrand factor and angiogenesis: basic and applied issues.

Authors:  A M Randi; M A Laffan
Journal:  J Thromb Haemost       Date:  2017-01       Impact factor: 5.824

Review 7.  αV integrins in angiogenesis and cancer.

Authors:  Sara M Weis; David A Cheresh
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

8.  Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

Authors:  R Soldi; S Mitola; M Strasly; P Defilippi; G Tarone; F Bussolino
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

9.  Expression of alphaV and beta3 integrin subunits during implantation in pig.

Authors:  Haichao Lin; Xin Wang; Guifen Liu; Jinlian Fu; Aiguo Wang
Journal:  Mol Reprod Dev       Date:  2007-11       Impact factor: 2.609

Review 10.  Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.

Authors:  Masabumi Shibuya
Journal:  J Biochem       Date:  2012-11-21       Impact factor: 3.387

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.